{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T08:21:25Z","timestamp":1794558085949,"version":"4.9.1"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,7,8]],"date-time":"2022-07-08T00:00:00Z","timestamp":1657238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,7,8]],"date-time":"2022-07-08T00:00:00Z","timestamp":1657238400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Psychiatry"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The burden associated with schizophrenia is substantial. Impacts on the individual, healthcare system, and society may be particularly striking within the veteran population due to the presence of physical and mental health comorbidities. Disease burden is also influenced by a complex interplay between social determinants of health and health disparities. The objective of the current study was to compare non-healthcare societal outcomes between veterans with and without schizophrenia in the United States Veterans Health Administration (VHA).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A retrospective cohort study was conducted using the VHA database (01\/2013\u201309\/2019; study period). Veterans with schizophrenia (\u22652 diagnoses of ICD-9295.xx, ICD-10 F20.x, F21, and\/or F25.x during the study period) were identified; the index date was the earliest observed schizophrenia diagnosis. Veterans with schizophrenia were propensity score-matched to those without schizophrenia using baseline characteristics. A 12-month baseline and variable follow-up period were applied. The frequency of unemployment, divorce, incarceration, premature death, and homelessness were compared between the matched cohorts using standardized mean difference (SMD). Risk of unemployment and homelessness were estimated using logistic regression models.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>A total of 102,207 veterans remained in each cohort after matching (91% male; 61% White [per AMA]; median age, 59\u2009years). Among veterans with schizophrenia, 42% had a substance use disorder and 30% had mental health-related comorbidities, compared with 25 and 15%, respectively, of veterans without schizophrenia. Veterans with schizophrenia were more likely to experience unemployment (69% vs. 41%; SMD: 0.81), divorce (35% vs. 28%; SMD: 0.67), homelessness (28% vs. 7%; SMD: 0.57), incarceration (0.4% vs. 0.1%; SMD: 0.47), and premature death (14% vs. 12%; SMD\u2009&lt;\u20090.1) than veterans without schizophrenia. After further adjustments, the risk of unemployment and of homelessness were 5.4 and 4.5 times higher among veterans with versus without schizophrenia. Other predictors of unemployment included Black [per AMA] race and history of substance use disorder; for homelessness, younger age (18\u201334\u2009years) and history of mental health-related comorbidities were additional predictors.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>A greater likelihood of adverse societal outcomes was observed among veterans with versus without schizophrenia. Given their elevated risk for unemployment and homelessness, veterans with schizophrenia should be a focus of targeted, multifactorial interventions to reduce disease burden.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12888-022-04022-x","type":"journal-article","created":{"date-parts":[[2022,7,8]],"date-time":"2022-07-08T11:03:06Z","timestamp":1657278186000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":54,"title":["Unemployment, homelessness, and other societal outcomes in patients with schizophrenia: a real-world retrospective cohort study of the United States Veterans Health Administration database"],"prefix":"10.1186","volume":"22","author":[{"given":"Dee","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyunchung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiko","family":"Wada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maya","family":"Aboumrad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ethan","family":"Powell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabrielle","family":"Zwain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmela","family":"Benson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aimee M.","family":"Near","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,7,8]]},"reference":[{"key":"4022_CR1","doi-asserted-by":"crossref","unstructured":"American Psychiatric Association. Practice guideline for the treatment of patients with schizophrenia. Third ed. Washington, DC: American Psychiatric Association; 2020.","DOI":"10.1176\/appi.books.9780890424841"},{"key":"4022_CR2","doi-asserted-by":"publisher","first-page":"2564","DOI":"10.2105\/AJPH.2015.302836","volume":"105","author":"RB Trivedi","year":"2015","unstructured":"Trivedi RB, Post EP, Sun H, Pomerantz A, Saxon AJ, Piette JD, et al. Prevalence, comorbidity, and prognosis of mental health among US veterans. Am J Public Health. 2015;105:2564\u20139. https:\/\/doi.org\/10.2105\/AJPH.2015.302836.","journal-title":"Am J Public Health"},{"key":"4022_CR3","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1001\/jamapsychiatry.2015.1737","volume":"72","author":"M Olfson","year":"2015","unstructured":"Olfson M, Gerhard T, Huang C, Crystal S, Stroup TS. Premature mortality among adults with schizophrenia in the United States. JAMA Psychiatry. 2015;72:1172\u201381. https:\/\/doi.org\/10.1001\/jamapsychiatry.2015.1737.","journal-title":"JAMA Psychiatry"},{"key":"4022_CR4","unstructured":"Veterans Association Health Services Research & Development Serious Mental Illness Treatment Resource and Evaluation Center. Care for Veterans With Psychosis in the Veterans Health Administration, FY09. Ann Arbor, Mich: 11th Annual National Psychosis Registry Report; 2009."},{"key":"4022_CR5","doi-asserted-by":"publisher","unstructured":"McCarthy JF, Bossarte RM, Katz IR, Thompson C, Kemp J, Hannemann CM, et al. Predictive modeling and concentration of the risk of suicide: implications for preventive interventions in the US Department of\u00a0Veterans Affairs. Am J Public Health. 2015;105:1935\u201342. https:\/\/doi.org\/10.2105\/AJPH.2015.302737.","DOI":"10.2105\/AJPH.2015.302737"},{"key":"4022_CR6","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1007\/s10597-019-00437-1","volume":"55","author":"MG Hunt","year":"2019","unstructured":"Hunt MG, Cuddeback GS, Bromley E, Bradford DW, Hoff RA. Changing rates of mental health disorders among veterans treated in the VHA during troop drawdown, 2007-2013. Community Ment Health J. 2019;55:1120\u20134. https:\/\/doi.org\/10.1007\/s10597-019-00437-1.","journal-title":"Community Ment Health J"},{"key":"4022_CR7","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1176\/appi.ps.201500507","volume":"67","author":"JL Goren","year":"2016","unstructured":"Goren JL, Rose AJ, Smith EG, Ney JP. The business case for expanded clozapine utilization. Psychiatr Serv. 2016;67:1197\u2013205. https:\/\/doi.org\/10.1176\/appi.ps.201500507.","journal-title":"Psychiatr Serv"},{"key":"4022_CR8","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.4088\/jcp.v66n0906","volume":"66","author":"EQ Wu","year":"2005","unstructured":"Wu EQ, Birnbaum HG, Shi L, Ball DE, Kessler RC, Moulis M, et al. The economic burden of schizophrenia in the United States in 2002. J Clin Psychiatry. 2005;66:1122\u20139. https:\/\/doi.org\/10.4088\/jcp.v66n0906.","journal-title":"J Clin Psychiatry."},{"key":"4022_CR9","doi-asserted-by":"publisher","first-page":"764","DOI":"10.4088\/JCP.15m10278","volume":"77","author":"M Cloutier","year":"2016","unstructured":"Cloutier M, Aigbogun MS, Guerin A, Nitulescu R, Ramanakumar AV, Kamat SA, et al. The economic burden of schizophrenia in the United States in 2013. J Clin Psychiatry. 2016;77:764\u201371. https:\/\/doi.org\/10.4088\/JCP.15m10278.","journal-title":"J Clin Psychiatry"},{"key":"4022_CR10","doi-asserted-by":"crossref","unstructured":"Wyatt RJ, Henter I, Leary MC, Taylor E. An economic evaluation of schizophrenia\u20131991. Soc Psychiatry Psychiatr Epidemiol. 1995;30:196\u2013205.","DOI":"10.1007\/BF00789054"},{"key":"4022_CR11","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1176\/ajp.132.9.901","volume":"132","author":"JG Gunderson","year":"1975","unstructured":"Gunderson JG, Mosher LR. The cost of schizophrenia. Am J Psychiatry. 1975;132:901\u20136. https:\/\/doi.org\/10.1176\/ajp.132.9.901.","journal-title":"Am J Psychiatry"},{"key":"4022_CR12","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1111\/jphs.12027","volume":"4","author":"PR Desai","year":"2013","unstructured":"Desai PR, Lawson KA, Barner JC, Rascati KL. Estimating the direct and indirect costs for community-dwelling patients with schizophrenia. J Pharm Health Serv Res. 2013;4:187\u201394.","journal-title":"J Pharm Health Serv Res"},{"key":"4022_CR13","doi-asserted-by":"publisher","first-page":"357","DOI":"10.2147\/NDT.S96649","volume":"12","author":"HY Chong","year":"2016","unstructured":"Chong HY, Teoh SL, Wu DB, Kotirum S, Chiou CF, Chaiyakunapruk N. Global economic burden of schizophrenia: a systematic review. Neuropsychiatr Dis Treat. 2016;12:357\u201373. https:\/\/doi.org\/10.2147\/NDT.S96649.","journal-title":"Neuropsychiatr Dis Treat"},{"key":"4022_CR14","volume-title":"The employment situation-October 2020","author":"United States Bureau of Labor Statistics","year":"2020","unstructured":"United States Bureau of Labor Statistics. The employment situation-October 2020. Washington, DC: U.S. Department of Labor; 2020. Available from: https:\/\/www.bls.gov\/news.release\/pdf\/empsit.pdf"},{"key":"4022_CR15","first-page":"57","volume":"39","author":"CE Ramsay","year":"2011","unstructured":"Ramsay CE, Goulding SM, Broussard B, Cristofaro SL, Abedi GR, Compton MT. Prevalence and psychosocial correlates of prior incarcerations in an urban, predominantly African-American sample of hospitalized patients with first-episode psychosis. J Am Acad Psychiatry Law. 2011;39:57\u201364.","journal-title":"J Am Acad Psychiatry Law"},{"key":"4022_CR16","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1186\/s12888-019-2361-7","volume":"19","author":"G Ayano","year":"2019","unstructured":"Ayano G, Tesfaw G, Shumet S. The prevalence of schizophrenia and other psychotic disorders among homeless people: a systematic review and meta-analysis. BMC Psychiatry. 2019;19:370. https:\/\/doi.org\/10.1186\/s12888-019-2361-7.","journal-title":"BMC Psychiatry."},{"key":"4022_CR17","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1001\/archpsyc.60.9.940","volume":"60","author":"R Rosenheck","year":"2003","unstructured":"Rosenheck R, Kasprow W, Frisman L, Liu-Mares W. Cost-effectiveness of supported housing for homeless persons with mental illness. Arch Gen Psychiatry. 2003;60:940\u201351. https:\/\/doi.org\/10.1001\/archpsyc.60.9.940.","journal-title":"Arch Gen Psychiatry"},{"key":"4022_CR18","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1080\/13696998.2018.1527608","volume":"21","author":"J Manjelievskaia","year":"2018","unstructured":"Manjelievskaia J, Amos TB, El Khoury AC, Vlahiotis A, Cole A, Juneau P. A comparison of treatment patterns, healthcare resource utilization, and costs among young adult Medicaid beneficiaries with schizophrenia treated with paliperidone palmitate or oral atypical antipsychotics in the US. J Med Econ. 2018;21:1221\u20139. https:\/\/doi.org\/10.1080\/13696998.2018.1527608.","journal-title":"J Med Econ"},{"key":"4022_CR19","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1186\/s12888-017-1358-3","volume":"17","author":"D Pilon","year":"2017","unstructured":"Pilon D, Muser E, Lefebvre P, Kamstra R, Emond B, Joshi K. Adherence, healthcare resource utilization and Medicaid spending associated with once-monthly paliperidone palmitate versus oral atypical antipsychotic treatment among adults recently diagnosed with schizophrenia. BMC Psychiatry. 2017;17:207. https:\/\/doi.org\/10.1186\/s12888-017-1358-3.","journal-title":"BMC Psychiatry"},{"key":"4022_CR20","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1111\/eip.12412","volume":"11","author":"J Immonen","year":"2017","unstructured":"Immonen J, Jaaskelainen E, Korpela H, Miettunen J. Age at onset and the outcomes of schizophrenia: a systematic review and meta-analysis. Early Interv Psychiatry. 2017;11:453\u201360. https:\/\/doi.org\/10.1111\/eip.12412.","journal-title":"Early Interv Psychiatry"},{"key":"4022_CR21","unstructured":"Huang A, Amos T, Joshi K, Wang L, Nash A. Burden of schizophrenia in recently diagnosed adult patients: a commercial payer perspective.\u00a0 New Orleans, Louisiana: 30th Annual Psych Congress;\u00a02017."},{"key":"4022_CR22","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/1744-859X-6-10","volume":"6","author":"M Pompili","year":"2007","unstructured":"Pompili M, Amador XF, Girardi P, Harkavy-Friedman J, Harrow M, Kaplan K, et al. Suicide risk in schizophrenia: learning from the past to change the future. Ann General Psychiatry. 2007;6:10. https:\/\/doi.org\/10.1186\/1744-859X-6-10.","journal-title":"Ann General Psychiatry"},{"key":"4022_CR23","unstructured":"United States Department of Veteran Affairs. VA mental health services public report. Washington DC: United States Department of Veteran Affairs; 2014. Available from: https:\/\/www.mentalhealth.va.gov\/docs\/Mental_Health_Transparency_Report_11-24-14.pdf."},{"key":"4022_CR24","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1097\/01.Mlr.0000093487.78664.3c","volume":"41","author":"K Kroenke","year":"2003","unstructured":"Kroenke K, Spitzer RL, Williams JB. The patient health Questionnaire-2: validity of a two-item depression screener. Med Care. 2003;41:1284\u201392. https:\/\/doi.org\/10.1097\/01.Mlr.0000093487.78664.3c.","journal-title":"Med Care"},{"key":"4022_CR25","unstructured":"Centers for Disease Control and Prevention (US). CDC National Health Report highlights. 2014. Available from: https:\/\/stacks.cdc.gov\/view\/cdc\/25808."},{"key":"4022_CR26","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.schres.2008.06.026","volume":"105","author":"MD Bell","year":"2008","unstructured":"Bell MD, Zito W, Greig T, Wexler BE. Neurocognitive enhancement therapy with vocational services: work outcomes at two-year follow-up. Schizophr Res. 2008;105:18\u201329. https:\/\/doi.org\/10.1016\/j.schres.2008.06.026.","journal-title":"Schizophr Res"},{"key":"4022_CR27","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1001\/jama.2009.561","volume":"301","author":"LS Sadowski","year":"2009","unstructured":"Sadowski LS, Kee RA, VanderWeele TJ, Buchanan D. Effect of a housing and case management program on emergency department visits and hospitalizations among chronically ill homeless adults: a randomized trial. Jama. 2009;301:1771\u20138. https:\/\/doi.org\/10.1001\/jama.2009.561.","journal-title":"Jama."},{"key":"4022_CR28","doi-asserted-by":"publisher","first-page":"3197","DOI":"10.2147\/NDT.S286654","volume":"16","author":"M Lambert","year":"2020","unstructured":"Lambert M, Sanchez P, Bergmans P, Gopal S, Mathews M, Wooller A, et al. Effect of paliperidone palmitate 3-month formulation on goal attainment and disability after 52 weeks' treatment in patients with clinically stable schizophrenia. Neuropsychiatr Dis Treat. 2020;16:3197\u2013208. https:\/\/doi.org\/10.2147\/NDT.S286654.","journal-title":"Neuropsychiatr Dis Treat"},{"key":"4022_CR29","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1097\/JGP.0b013e3182096ae5","volume":"20","author":"SR Thorp","year":"2012","unstructured":"Thorp SR, Sones HM, Glorioso D, Thompson W, Light GA, Golshan S, et al. Older patients with schizophrenia: does military veteran status matter? Am J Geriatr Psychiatry. 2012;20:248\u201356. https:\/\/doi.org\/10.1097\/JGP.0b013e3182096ae5.","journal-title":"Am J Geriatr Psychiatry"},{"key":"4022_CR30","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1176\/ps.2007.58.4.489","volume":"58","author":"JA Kreyenbuhl","year":"2007","unstructured":"Kreyenbuhl JA, Valenstein M, McCarthy JF, Ganoczy D, Blow FC. Long-term antipsychotic polypharmacy in the VA health system: patient characteristics and treatment patterns. Psychiatr Serv. 2007;58:489\u201395. https:\/\/doi.org\/10.1176\/ps.2007.58.4.489.","journal-title":"Psychiatr Serv"},{"key":"4022_CR31","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1093\/schbul\/sbn135","volume":"35","author":"PF Buckley","year":"2009","unstructured":"Buckley PF, Miller BJ, Lehrer DS, Castle DJ. Psychiatric comorbidities and schizophrenia. Schizophr Bull. 2009;35:383\u2013402. https:\/\/doi.org\/10.1093\/schbul\/sbn135.","journal-title":"Schizophr Bull"},{"key":"4022_CR32","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1007\/s11920-004-0074-0","volume":"6","author":"JE Muller","year":"2004","unstructured":"Muller JE, Koen L, Soraya S, Emsley RA, Stein DJ. Anxiety disorders and schizophrenia. Curr Psychiatry Rep. 2004;6:255\u201361. https:\/\/doi.org\/10.1007\/s11920-004-0074-0.","journal-title":"Curr Psychiatry Rep."},{"key":"4022_CR33","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.psychres.2013.05.013","volume":"210","author":"J Tsai","year":"2013","unstructured":"Tsai J, Rosenheck RA. Psychiatric comorbidity among adults with schizophrenia: a latent class analysis. Psychiatry Res. 2013;210:16\u201320. https:\/\/doi.org\/10.1016\/j.psychres.2013.05.013.","journal-title":"Psychiatry Res"},{"key":"4022_CR34","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1001\/archpsyc.62.6.593","volume":"62","author":"RC Kessler","year":"2005","unstructured":"Kessler RC, Berglund P, Demler O, Jin R, Merikangas KR, Walters EE. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2005;62:593\u2013602. https:\/\/doi.org\/10.1001\/archpsyc.62.6.593.","journal-title":"Arch Gen Psychiatry"},{"key":"4022_CR35","unstructured":"National Institute of Mental Health. Generalized anxiety disorder 2017. Available from: https:\/\/www.nimh.nih.gov\/health\/statistics\/generalized-anxietydisorder.shtml#:~:text=An%20estimated%202.7%25%20of%20U.S.,than%20for%20males%20(1.9%25)."},{"key":"4022_CR36","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1001\/jamapsychiatry.2015.2132","volume":"73","author":"BF Grant","year":"2016","unstructured":"Grant BF, Saha TD, Ruan WJ, Goldstein RB, Chou SP, Jung J, et al. Epidemiology of DSM-5 drug use disorder: results from the National Epidemiologic Survey on alcohol and related conditions-III. JAMA Psychiatry. 2016;73:39\u201347. https:\/\/doi.org\/10.1001\/jamapsychiatry.2015.2132.","journal-title":"JAMA Psychiatry."},{"key":"4022_CR37","unstructured":"The Council of Economic Advisers. The state of homelessness in America. 2019. Available from: https:\/\/www.whitehouse.gov\/wp-content\/uploads\/2019\/09\/The-State-of-Homelessness-in-America.pdf."},{"key":"4022_CR38","unstructured":"US Department of Housing and Urban Development. Cost associated with first-time homelessness for families and individuals. 2010. Available from: https:\/\/www.huduser.gov\/publications\/pdf\/Costs_Homeless.pdf."},{"key":"4022_CR39","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/s11920-018-0969-9","volume":"20","author":"M Alegria","year":"2018","unstructured":"Alegria M, NeMoyer A, Falgas Bague I, Wang Y, Alvarez K. Social determinants of mental health: where we are and where we need to go. Curr Psychiatry Rep. 2018;20:95. https:\/\/doi.org\/10.1007\/s11920-018-0969-9.","journal-title":"Curr Psychiatry Rep"},{"key":"4022_CR40","volume-title":"Social determinants of mental health","author":"World Health Organization and Calouste Gulbenkian Foundation","year":"2014","unstructured":"World Health Organization and Calouste Gulbenkian Foundation. Social determinants of mental health. Geneva, Switzerland: World Health Organization; 2014. Available from: https:\/\/www.who.int\/mental_health\/publications\/gulbenkian_paper_social_determinants_of_mental_health\/en\/"},{"issue":"Suppl 1","key":"4022_CR41","doi-asserted-by":"publisher","first-page":"S131","DOI":"10.2105\/AJPH.2011.300445","volume":"102","author":"MS Kaplan","year":"2012","unstructured":"Kaplan MS, McFarland BH, Huguet N, Valenstein M. Suicide risk and precipitating circumstances among young, middle-aged, and older male veterans. Am J Public Health. 2012;102(Suppl 1):S131\u20137. https:\/\/doi.org\/10.2105\/AJPH.2011.300445.","journal-title":"Am J Public Health"},{"key":"4022_CR42","first-page":"1","volume":"30","author":"L Lee","year":"2019","unstructured":"Lee L. PTSD and aging. PTSD Research Quarterly. 2019;30:1\u20135.","journal-title":"PTSD Research Quarterly"},{"key":"4022_CR43","doi-asserted-by":"crossref","unstructured":"Tanielian T, Jaycox LH, Schell TL, Marshall GN, Burnam MA, Eibner C, et al. Invisible wounds. mental health and cognitive care needs of America's returning veterans: RAND Corporation; 2008.","DOI":"10.7249\/RB9336"},{"key":"4022_CR44","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/j.psychres.2016.08.054","volume":"245","author":"J Logan","year":"2016","unstructured":"Logan J, Bohnert A, Spies E, Jannausch M. Suicidal ideation among young Afghanistan\/Iraq war veterans and civilians: individual, social, and environmental risk factors and perception of unmet mental healthcare needs, United States, 2013. Psychiatry Res. 2016;245:398\u2013405. https:\/\/doi.org\/10.1016\/j.psychres.2016.08.054.","journal-title":"Psychiatry Res"},{"key":"4022_CR45","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1016\/j.psychres.2014.08.046","volume":"220","author":"CL Hui","year":"2014","unstructured":"Hui CL, Li AW, Leung CM, Chang WC, Chan SK, Lee EH, et al. Comparing illness presentation, treatment and functioning between patients with adolescent- and adult-onset psychosis. Psychiatry Res. 2014;220:797\u2013802. https:\/\/doi.org\/10.1016\/j.psychres.2014.08.046.","journal-title":"Psychiatry Res"},{"key":"4022_CR46","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/s40501-017-0115-z","volume":"4","author":"S Miyamoto","year":"2017","unstructured":"Miyamoto S, Wolfgang FW. The use of long-acting injectable antipsychotics in schizophrenia. Curr Treat Options Psychiatry. 2017;4:117\u201326. https:\/\/doi.org\/10.1007\/s40501-017-0115-z.","journal-title":"Curr Treat Options Psychiatry"},{"key":"4022_CR47","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.psychres.2004.10.004","volume":"133","author":"A Pencer","year":"2005","unstructured":"Pencer A, Addington J, Addington D. Outcome of a first episode of psychosis in adolescence: a 2-year follow-up. Psychiatry Res. 2005;133:35\u201343. https:\/\/doi.org\/10.1016\/j.psychres.2004.10.004.","journal-title":"Psychiatry Res"},{"key":"4022_CR48","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/j.genhosppsych.2009.07.008","volume":"31","author":"AM Kilbourne","year":"2009","unstructured":"Kilbourne AM, Morden NE, Austin K, Ilgen M, McCarthy JF, Dalack G, et al. Excess heart-disease-related mortality in a national study of patients with mental disorders: identifying modifiable risk factors. Gen Hosp Psychiatry. 2009;31:555\u201363. https:\/\/doi.org\/10.1016\/j.genhosppsych.2009.07.008.","journal-title":"Gen Hosp Psychiatry"},{"key":"4022_CR49","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/S2215-0366(17)30079-2","volume":"4","author":"CA Galletly","year":"2017","unstructured":"Galletly CA. Premature death in schizophrenia: bridging the gap. Lancet Psychiatry. 2017;4:263\u20135. https:\/\/doi.org\/10.1016\/S2215-0366(17)30079-2.","journal-title":"Lancet Psychiatry"},{"key":"4022_CR50","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1186\/1471-2458-11-374","volume":"11","author":"J Weiner","year":"2011","unstructured":"Weiner J, Richmond TS, Conigliaro J, Wiebe DJ. Military veteran mortality following a survived suicide attempt. BMC Public Health. 2011;11:374. https:\/\/doi.org\/10.1186\/1471-2458-11-374.","journal-title":"BMC Public Health"},{"key":"4022_CR51","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1192\/bjp.177.3.212","volume":"177","author":"S Brown","year":"2000","unstructured":"Brown S, Inskip H, Barraclough B. Causes of the excess mortality of schizophrenia. Br J Psychiatry. 2000;177:212\u20137. https:\/\/doi.org\/10.1192\/bjp.177.3.212.","journal-title":"Br J Psychiatry"},{"key":"4022_CR52","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.amepre.2019.03.014","volume":"57","author":"JA Forehand","year":"2019","unstructured":"Forehand JA, Peltzman T, Westgate CL, Riblet NB, Watts BV, Shiner B. Causes of excess mortality in veterans treated for posttraumatic stress disorder. Am J Prev Med. 2019;57:145\u201352. https:\/\/doi.org\/10.1016\/j.amepre.2019.03.014.","journal-title":"Am J Prev Med"},{"key":"4022_CR53","doi-asserted-by":"publisher","first-page":"110","DOI":"10.3969\/j.issn.1002-0829.2012.02.007","volume":"24","author":"DL Kelly","year":"2012","unstructured":"Kelly DL, Wehring HJ, Vyas G. Current status of clozapine in the United States. Shanghai Arch Psychiatry. 2012;24:110\u20133. https:\/\/doi.org\/10.3969\/j.issn.1002-0829.2012.02.007.","journal-title":"Shanghai Arch Psychiatry"},{"key":"4022_CR54","doi-asserted-by":"publisher","first-page":"e1332","DOI":"10.4088\/JCP.16m10745","volume":"77","author":"Y Young-Xu","year":"2016","unstructured":"Young-Xu Y, Duh MS, Muser E, DerSarkissian M, Faust E, Kageleiry A, et al. Impact of paliperidone palmitate versus oral atypical antipsychotics on health care resource use and costs in veterans with schizophrenia. J Clin Psychiatry. 2016;77:e1332\u2013e41. https:\/\/doi.org\/10.4088\/JCP.16m10745.","journal-title":"J Clin Psychiatry."},{"key":"4022_CR55","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4088\/JCP.15032su1","volume":"77","author":"CU Correll","year":"2016","unstructured":"Correll CU, Citrome L, Haddad PM, Lauriello J, Olfson M, Calloway SM, et al. The use of long-acting injectable antipsychotics in schizophrenia: evaluating the evidence. J Clin Psychiatry. 2016;77:1\u201324. https:\/\/doi.org\/10.4088\/JCP.15032su1.","journal-title":"J Clin Psychiatry."},{"key":"4022_CR56","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.eurpsy.2009.12.020","volume":"26","author":"S Heres","year":"2011","unstructured":"Heres S, Reichhart T, Hamann J, Mendel R, Leucht S, Kissling W. Psychiatrists' attitude to antipsychotic depot treatment in patients with first-episode schizophrenia. Eur Psychiatry. 2011;26:297\u2013301. https:\/\/doi.org\/10.1016\/j.eurpsy.2009.12.020.","journal-title":"Eur Psychiatry"},{"key":"4022_CR57","doi-asserted-by":"publisher","first-page":"560836","DOI":"10.1155\/2012\/560836","volume":"2012","author":"B Kim","year":"2012","unstructured":"Kim B, Lee SH, Yang YK, Park JI, Chung YC. Long-acting injectable antipsychotics for first-episode schizophrenia: the pros and cons. Schizophr Res Treatment. 2012;2012:560836. https:\/\/doi.org\/10.1155\/2012\/560836.","journal-title":"Schizophr Res Treatment"},{"key":"4022_CR58","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1177\/0269881109104882","volume":"24","author":"MX Patel","year":"2010","unstructured":"Patel MX, Haddad PM, Chaudhry IB, McLoughlin S, Husain N, David AS. Psychiatrists' use, knowledge and attitudes to first- and second-generation antipsychotic long-acting injections: comparisons over 5 years. J Psychopharmacol. 2010;24:1473\u201382. https:\/\/doi.org\/10.1177\/0269881109104882.","journal-title":"J Psychopharmacol"},{"key":"4022_CR59","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1007\/s40263-021-00861-6","volume":"35","author":"JM Kane","year":"2021","unstructured":"Kane JM, McEvoy JP, Correll CU, Llorca PM. Controversies surrounding the use of long-acting injectable antipsychotic medications for the treatment of patients with schizophrenia. CNS Drugs. 2021;35:1189\u2013205. https:\/\/doi.org\/10.1007\/s40263-021-00861-6.","journal-title":"CNS Drugs"},{"key":"4022_CR60","doi-asserted-by":"publisher","unstructured":"Tsai J, Szymkowiak D, Radhakrishnan R. Antipsychotic medication prescriptions for homeless and unstably housed veterans in the veterans affairs health care system. J Clin Psychiatry. 2020;82:20m13372. https:\/\/doi.org\/10.4088\/JCP.20m13372.","DOI":"10.4088\/JCP.20m13372"},{"key":"4022_CR61","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/s0193-953x(02)00014-x","volume":"26","author":"AI Green","year":"2003","unstructured":"Green AI, Canuso CM, Brenner MJ, Wojcik JD. Detection and management of comorbidity in patients with schizophrenia. Psychiatr Clin North Am. 2003;26:115\u201339. https:\/\/doi.org\/10.1016\/s0193-953x(02)00014-x.","journal-title":"Psychiatr Clin North Am"},{"key":"4022_CR62","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1176\/appi.ajp.161.1.1","volume":"161","author":"AF Lehman","year":"2004","unstructured":"Lehman AF, Lieberman JA, Dixon LB, McGlashan TH, Miller AL, Perkins DO, et al. Practice guideline for the treatment of patients with schizophrenia, second edition. Am J Psychiatry. 2004;161:1\u201356.","journal-title":"Am J Psychiatry"},{"key":"4022_CR63","doi-asserted-by":"publisher","first-page":"61","DOI":"10.31887\/DCNS.2004.6.1\/acaspi","volume":"6","author":"A Caspi","year":"2004","unstructured":"Caspi A, Davidson M, Tamminga CA. Treatment-refractory schizophrenia. Dialogues Clin Neurosci. 2004;6:61\u201370.","journal-title":"Dialogues Clin Neurosci"},{"key":"4022_CR64","unstructured":"National Alliance on Mental Illness. Protecting veterans' access to mental health care.\u00a02020. Available from: https:\/\/www.nami.org\/Advocacy\/Policy-Priorities\/Improve-Care\/Protecting-Veterans-Access-to-Mental-Health-Care."}],"container-title":["BMC Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-022-04022-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12888-022-04022-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-022-04022-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,8]],"date-time":"2022-07-08T11:05:15Z","timestamp":1657278315000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpsychiatry.biomedcentral.com\/articles\/10.1186\/s12888-022-04022-x"}},"subtitle":["Societal burden of schizophrenia among US veterans"],"short-title":[],"issued":{"date-parts":[[2022,7,8]]},"references-count":64,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["4022"],"URL":"https:\/\/doi.org\/10.1186\/s12888-022-04022-x","relation":{},"ISSN":["1471-244X"],"issn-type":[{"value":"1471-244X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,8]]},"assertion":[{"value":"13 May 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 May 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethics approval for this study was obtained from the Veterans Affairs Central Institutional Review Board on December 17, 2019 (IRBnetID: 1478231\u20131). The requirement to obtain informed consent from study participants was waived by the Veterans Affairs Central Institutional Review Board; it was determined that this study involves no more than a minimal risk to the privacy of individuals. Data used in the study were de-identified and only aggregated results are shared. In addition, this study was performed in accordance with the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Dee Lin and Carmela Benson are employees of Janssen Scientific Affairs, LLC; Hyunchung Kim, Keiko Wada, and Aimee Near are employees of IQVIA, and IQVIA was paid by Janssen to conduct the research study; Maya Aboumrad, Ethan Powell, and Gabrielle Zwain are employees of the Clinical Epidemiology Program at the White River Junction VA\u00a0Medical Center, and the Clinical Epidemiology Program was paid by IQVIA to conduct data analysis.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"458"}}